You can like or dislike Obamacare, but what innovators and business leaders hate is the constant instability of not knowing what rules they need to play by/innovate in.
It seems the back-and-forth aspect of these constant repeals finally has some Republicans fed up now, too.
Republicans John Katko of New York, Bruce Poliquin of Maine and Robert Dold of Illinois voted against full Obamacare repeal. This marks the first time Republicans in Congress have voted against repeal since this all started back in 2011. The House passed the bill with a 239 to 186 vote, which now sends it to the Senate. No Democrats voted for repeal.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
In statements, Katko and Poliquin both said they couldn’t support the repeal without having a solid replacement plan, Politico reported.
“Had Congress voted for the full repeal of Obamacare two years ago, families and small businesses would have been able to adjust to the change. Now, however, more than 60,000 Mainers have invested their time and energy in choosing health care plans that work for their families,” Poliquin said in a statement. “If Congress fully repeals Obamacare, it must be fully prepared to replace it with a free-market alternative.”
Many Democrats continue to believe the repeal bills are a complete waste of time, not just by citing that Obamacare is working or that Republicans have no clear alternative, but Obama has said he will undoubtedly veto the bill regardless.
“Republicans,” said Representative Nancy Pelosi of California, the House Democratic leader, according to The New York Times, “are baying at the moon. Instead of proposing any good suggestions they may have to improve the Affordable Care Act, they are baying at the moon.”
Of course, later this year the Supreme Court is expected to rule on whether or not to uphold a challenge to insurance subsidies now being provided to millions of people under the law, which will be huge.
Innovators and business leaders are going to have to hang tight still, But a veto from Obama provides some security in the ACA standing.
No doubt, the debate will continue.
